Cellular and Molecular Life Sciences CMLS

, Volume 57, Issue 2, pp 235–249

RNA processing and human disease

Authors

  • A. V. Philips
    • Department of Pathology, Baylor College of Medicine, Houston (Texas 77030, USA), Fax +1 713 798 5838, e-mail: tcooper@bcm.tmc.edu
  • T. A. Cooper*
    • Department of Pathology, Baylor College of Medicine, Houston (Texas 77030, USA), Fax +1 713 798 5838, e-mail: tcooper@bcm.tmc.edu

DOI: 10.1007/PL00000687

Cite this article as:
Philips, A. & Cooper*, T. CMLS, Cell. Mol. Life Sci. (2000) 57: 235. doi:10.1007/PL00000687

Abstract.

Gene expression involves multiple regulated steps leading from gene to active protein. Many of these steps involve some aspect of RNA processing. Diseases caused by mutations that directly affect RNA processing are relatively rare compared with mutations that disrupt protein function. The vast majority of diseases of RNA processing result from loss of function of a single gene due to mutations in cis-acting elements required for pre-messenger RNA (mRNA) splicing. However, a few diseases are caused by alterations in the trans-actingfactors required for RNA processing and in the vast majority of cases it is the pre-mRNA splicing machinery that is affected. Clearly, alterations that disrupt splicing of pre-mRNAs from large numbers of genes would be lethal at the cellular level. A common theme among these diseases is that only subsets of genes are affected. This is consistent with an emerging view that different subsets of exons require different sets of cis-acting elements and trans-acting factors.

Key words. Pre-mRNA; alternative splicing; spliceosome; U2AF.

Copyright information

© Birkhäuser Verlag Basel, 2000